| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.07 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.077 | 0.08 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.08 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.09 |